Trial intelligence / Profile preview

Topical tranexamic acid for post-mastectomy wound drainage and seroma formation

PACTR202410898508805Completed

Sponsor
Adegoke Ishola
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Trial of tranexamic acid in breast cancer (2 arms), sponsored by Adegoke Ishola. Primary endpoints: Wound drainage and Seroma formation. Started Apr 2023; status: completed.

02

Drugs

tranexamic acid
03

Conditions

breast cancer

Beyond the preview

Go deeper on PACTR202410898508805.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202410898508805.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call